These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

515 related items for PubMed ID: 12791810

  • 1. Initial human PET imaging studies with the dopamine transporter ligand 18F-FECNT.
    Davis MR, Votaw JR, Bremner JD, Byas-Smith MG, Faber TL, Voll RJ, Hoffman JM, Grafton ST, Kilts CD, Goodman MM.
    J Nucl Med; 2003 Jun; 44(6):855-61. PubMed ID: 12791810
    [Abstract] [Full Text] [Related]

  • 2. 18F-labeled FECNT: a selective radioligand for PET imaging of brain dopamine transporters.
    Goodman MM, Kilts CD, Keil R, Shi B, Martarello L, Xing D, Votaw J, Ely TD, Lambert P, Owens MJ, Camp VM, Malveaux E, Hoffman JM.
    Nucl Med Biol; 2000 Jan; 27(1):1-12. PubMed ID: 10755640
    [Abstract] [Full Text] [Related]

  • 3. Progression of dopaminergic hypofunction in striatal subregions in Parkinson's disease using [18F]CFT PET.
    Nurmi E, Bergman J, Eskola O, Solin O, Vahlberg T, Sonninen P, Rinne JO.
    Synapse; 2003 Jun 01; 48(3):109-15. PubMed ID: 12645035
    [Abstract] [Full Text] [Related]

  • 4. Rapid detection of Parkinson's disease by SPECT with altropane: a selective ligand for dopamine transporters.
    Fischman AJ, Bonab AA, Babich JW, Palmer EP, Alpert NM, Elmaleh DR, Callahan RJ, Barrow SA, Graham W, Meltzer PC, Hanson RN, Madras BK.
    Synapse; 1998 Jun 01; 29(2):128-41. PubMed ID: 9593103
    [Abstract] [Full Text] [Related]

  • 5. Potential of [(18)F]beta-CFT-FE (2beta-carbomethoxy-3beta-(4-fluorophenyl)-8-(2-[(18)F]fluoroethyl)nortropane) as a dopamine transporter ligand: A PET study in the conscious monkey brain.
    Harada N, Ohba H, Fukumoto D, Kakiuchi T, Tsukada H.
    Synapse; 2004 Oct 01; 54(1):37-45. PubMed ID: 15300883
    [Abstract] [Full Text] [Related]

  • 6. PET imaging of the dopamine transporter with 18F-FECNT: a polar radiometabolite confounds brain radioligand measurements.
    Zoghbi SS, Shetty HU, Ichise M, Fujita M, Imaizumi M, Liow JS, Shah J, Musachio JL, Pike VW, Innis RB.
    J Nucl Med; 2006 Mar 01; 47(3):520-7. PubMed ID: 16513622
    [Abstract] [Full Text] [Related]

  • 7. Progression in Parkinson's disease: a positron emission tomography study with a dopamine transporter ligand [18F]CFT.
    Nurmi E, Ruottinen HM, Kaasinen V, Bergman J, Haaparanta M, Solin O, Rinne JO.
    Ann Neurol; 2000 Jun 01; 47(6):804-8. PubMed ID: 10852547
    [Abstract] [Full Text] [Related]

  • 8. Reproducibility and effect of levodopa on dopamine transporter function measurements: a [18F]CFT PET study.
    Nurmi E, Bergman J, Eskola O, Solin O, Hinkka SM, Sonninen P, Rinne JO.
    J Cereb Blood Flow Metab; 2000 Nov 01; 20(11):1604-9. PubMed ID: 11083235
    [Abstract] [Full Text] [Related]

  • 9. Synthesis and Biological Evaluation of [18F]FECNT-d4 as a Novel PET Agent for Dopamine Transporter Imaging.
    Cao S, Tang J, Liu C, Fang Y, Ji L, Xu Y, Chen Z.
    Mol Imaging Biol; 2021 Oct 01; 23(5):733-744. PubMed ID: 33851345
    [Abstract] [Full Text] [Related]

  • 10. Dopamine transporter imaging with fluorine-18-FPCIT and PET.
    Kazumata K, Dhawan V, Chaly T, Antonini A, Margouleff C, Belakhlef A, Neumeyer J, Eidelberg D.
    J Nucl Med; 1998 Sep 01; 39(9):1521-30. PubMed ID: 9744335
    [Abstract] [Full Text] [Related]

  • 11. Quantitative Analysis of ¹⁸F-(E)-N-(3-Iodoprop-2-Enyl)-2β-Carbofluoroethoxy-3β-(4'-Methyl-Phenyl) Nortropane Binding to the Dopamine Transporter in Parkinson Disease.
    Fazio P, Svenningsson P, Forsberg A, Jönsson EG, Amini N, Nakao R, Nag S, Halldin C, Farde L, Varrone A.
    J Nucl Med; 2015 May 01; 56(5):714-20. PubMed ID: 25791993
    [Abstract] [Full Text] [Related]

  • 12. Caudate nucleus: influence of dopaminergic input on sequence learning and brain activation in Parkinsonism.
    Carbon M, Ma Y, Barnes A, Dhawan V, Chaly T, Ghilardi MF, Eidelberg D.
    Neuroimage; 2004 Apr 01; 21(4):1497-507. PubMed ID: 15050574
    [Abstract] [Full Text] [Related]

  • 13. Synthesis, biodistribution, and primate imaging of fluorine-18 labeled 2beta-carbo-1'-fluoro-2-propoxy-3beta-(4-chlorophenyl)tr opanes. Ligands for the imaging of dopamine transporters by positron emission tomography.
    Xing D, Chen P, Keil R, Kilts CD, Shi B, Camp VM, Malveaux G, Ely T, Owens MJ, Votaw J, Davis M, Hoffman JM, BaKay RA, Subramanian T, Watts RL, Goodman MM.
    J Med Chem; 2000 Feb 24; 43(4):639-48. PubMed ID: 10691690
    [Abstract] [Full Text] [Related]

  • 14. Quantification of dopamine transporter density with [18F]FECNT PET in healthy humans.
    Nye JA, Votaw JR, Bremner JD, Davis MR, Voll RJ, Camp VM, Goodman MM.
    Nucl Med Biol; 2014 Mar 24; 41(3):217-22. PubMed ID: 24533985
    [Abstract] [Full Text] [Related]

  • 15. Fluorine-18-FPCT: a PET radiotracer for imaging dopamine transporters.
    Goodman MM, Keil R, Shoup TM, Eshima D, Eshima L, Kilts C, Votaw J, Camp VM, Votaw D, Smith E, Kung MP, Malveaux E, Watts R, Huerkamp M, Wu D, Garcia E, Hoffman JM.
    J Nucl Med; 1997 Jan 24; 38(1):119-26. PubMed ID: 8998165
    [Abstract] [Full Text] [Related]

  • 16. [(11)C]PE2I: a highly selective radioligand for PET examination of the dopamine transporter in monkey and human brain.
    Halldin C, Erixon-Lindroth N, Pauli S, Chou YH, Okubo Y, Karlsson P, Lundkvist C, Olsson H, Guilloteau D, Emond P, Farde L.
    Eur J Nucl Med Mol Imaging; 2003 Sep 24; 30(9):1220-30. PubMed ID: 12811422
    [Abstract] [Full Text] [Related]

  • 17. N,N-dimethyl-2-(2-amino-4-(18)F-fluorophenylthio)-benzylamine (4-(18)F-ADAM): an improved PET radioligand for serotonin transporters.
    Shiue GG, Choi SR, Fang P, Hou C, Acton PD, Cardi C, Saffer JR, Greenberg JH, Karp JS, Kung HF, Shiue CY.
    J Nucl Med; 2003 Dec 24; 44(12):1890-7. PubMed ID: 14660713
    [Abstract] [Full Text] [Related]

  • 18. [[123I]beta-CIT SPECT imaging of dopamine and serotonin transporters in Parkinson's disease and multiple system atrophy.
    Berding G, Brücke T, Odin P, Brooks DJ, Kolbe H, Gielow P, Harke H, Knoop BO, Dengler R, Knapp WH.
    Nuklearmedizin; 2003 Feb 24; 42(1):31-8. PubMed ID: 12601452
    [Abstract] [Full Text] [Related]

  • 19. (18)F-FECNT: validation as PET dopamine transporter ligand in parkinsonism.
    Masilamoni G, Votaw J, Howell L, Villalba RM, Goodman M, Voll RJ, Stehouwer J, Wichmann T, Smith Y.
    Exp Neurol; 2010 Dec 24; 226(2):265-73. PubMed ID: 20832405
    [Abstract] [Full Text] [Related]

  • 20. Semi-automated preparation of the dopamine transporter ligand [(18)F]FECNT for human PET imaging studies.
    Voll RJ, McConathy J, Waldrep MS, Crowe RJ, Goodman MM.
    Appl Radiat Isot; 2005 Sep 24; 63(3):353-61. PubMed ID: 15985372
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.